Postacute ischemia vascular endothelial growth factor transfer by transferrin-targeted liposomes attenuates ischemic brain injury after experimental stroke in rats

Human Gene Therapy

Volumn 22, Issue 2, 2011, Pages 207-215

  Zhao, Hao ^a,b   Bao, Xin Jie ^a   Wang, Ren Zhi ^a   Li, Gui Lin ^a   Gao, Jun ^a   Ma, Si Hai ^a   Wei, Jun Ji ^a   Feng, Ming ^a   Zhao, Ying Jie ^a   Ma, Wen Bin ^a   Yang, Yi ^a   Li, Yong Ning ^a   Kong, Yan Guo ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; LIPOSOME; MESSENGER RNA; SODIUM CHLORIDE; TRANSFERRIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION; BRAIN ISCHEMIA; DRUG EFFECT; GENE EXPRESSION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; LIPOSOMAL GENE DELIVERY SYSTEM; MALE; NEUROPROTECTION; NONHUMAN; RAT;

ANIMALS; BETA-GALACTOSIDASE; BRAIN; BRAIN ISCHEMIA; DEXTRANS; DISEASE MODELS, ANIMAL; FLUORESCEIN-5-ISOTHIOCYANATE; GENE THERAPY; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; STROKE; TRANSFERRIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 79951827524     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.111     Document Type: Article

References (39)

1. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
2. Chen, J., Li, Y., Wang, L., Zhang, Z.G., Lu, D., Lu, M., and Chopp, M. (2001a). Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32, 1005-1011. (Pubitemid 32285175)
3. Chen, J., Sanberg, P.R., Li, Y., Wang, L., Lu, M., Willing, A.E., Sanchez-Ramos, J., and Chopp, M. (2001b). Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688. (Pubitemid 33055324)
4. Chu, K., Park, K.I., Lee, S.T., Jung, K.H., Ko, S.Y., Kang, L., Sinn, D.I., Lee,Y.S., Kim, S.U., Kim, M., and Roh, J.K. (2005). Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. Neurosci. Res. 53, 384-390. (Pubitemid 41643065)
5. Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., and Harashima, H. (2004). Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int. J. Pharm. 281, 25-33. (Pubitemid 39024260)
6. Hermann, D.M., and Zechariah, A. (2009). Implications of vascular endothelial growth factor for postischemic neurovas-cular remodeling. J. Cereb. Blood Flow Metab. 29, 1620-1643.
7. Ito, A., Kuga, Y., and Honda, H. (2004). Magnetic nanoparticle-loaded anti-immunoliposomes for combination of antibody therapy with hyperthermia. Cancer Lett. 212, 167-175. (Pubitemid 39004092)
8. Kitagawa, K., Matsumoto, M., Kuwabara, K., Ohtsuki, T., and Hori, M. (2001). Delayed, but marked, expression of apolipo-protein E is involved in tissue clearance after cerebral infarction. J. Cereb. Blood Flow Metab. 21, 1199-1207. (Pubitemid 32947486)
9. Li, H., and Qian, Z.M. (2002). Transferrin/transferrin receptor mediated drug delivery. Med. Res. Rev. 22, 225-250. (Pubitemid 34415465)
10. Li, Y., Chen, J., Wang, L., Lu, M., Chopp, M. (2001). Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology 56, 1666-1672. (Pubitemid 32574564)
11. -DDCT method. Methods 25, 402-408. (Pubitemid 34164012)
12. Longa, E.Z., Weinstein, P.R., Carlson, S., and Cummins, R. (1989). Reversible middle cerebral-artery occlusion without craniectomy in rats. Stroke 20, 84-91. (Pubitemid 19040218)
13. Lu, W., Zhang, Y., Tan, Y.Z., Hu, K.L., Jiang, X.G., and Fu, S.K. (2005). Cationic albumin-conjugated PEGylated nanoparticles as novel drug carrier for brain delivery. J. Control. Release 107, 428-448. (Pubitemid 41393353)
14. Maeda, N., Takeuchi, Y., Takada, M., Sadzuka, Y., Namba, Y., and Oku, N. (2004). Antineovascular therapy by use of tumor neovasculature-targeted long circulating liposome. J. Control. Release 100, 41-52. (Pubitemid 39445984)
15. Moreira, J.N., Gaspar, R., and Allen, T.M. (2001). Targeting stealth liposomes in a murine model of human small cell lung cancer. Biochim. Biophys. Acta 1515, 167-176. (Pubitemid 33086833)
16. Munehisa, S., Naoyuki, S., Shinichi, Y., Yasufumi, K., and Ryuichi, M. (2006). HVJ-based non-viral gene transfer method: Successful gene therapy using HGF and VEGF genes in experimental ischemia. Front. Biosci. 11, 753-759.
17. Omori, N., Maruyama, K., Jin, G., Li, F., Wang, S. J., Hamakawa, Y., Sato, K., Nagano, I., Shoji, M., and Abe, K. (2003). Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin. Neurol. Res. 25, 275-279. (Pubitemid 36520484)
18. Pardridge, W.M. (1999). Blood-brain barrier biology and methodology. J. Neurovirol. 5, 556-569. (Pubitemid 30032082)
19. Pardridge, W.M. (2001). Brain drug targeting and gene technologies. Jpn. J. Pharmacol. 87, 97-103.
20. Pardridge, W.M. (2002). Drug and gene delivery to the brain: The vascular route. Neuron 36, 555-558. (Pubitemid 35346750)
21. Qian, Z.M., Li, H., Sun, H., and Ho, K. (2002). Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54, 561-587. (Pubitemid 35351196)
22. Reddy, M.K., and Labhasetwar, V. (2009). Nanoparticle-mediated delivery of superoxide dismutase to the brain: An effective strategy to reduce ischemia-reperfusion injury. FASEB J. 23, 1384-1395.
23. Sako, K., Okuma, Y., Hosoi, T., and Nomura, Y. (2005). STAT3 activation and c-FOS expression in the brain following peripheral administration of bacterial DNA. J. Neuroimmunol. 158, 40-49. (Pubitemid 39626069)
24. Schallert, T., Upchurch, M., Lobaugh, N., Farrar S.B., Spirduso W.W., Gilliam P., Vaughn D., and Wilcox R.E. (1982). Tactile extinction: Distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol. Biochem. Behav. 16, 455-462. (Pubitemid 12147019)
25. Schlachetzki, F., Zhang, Y., Boado, R., and Pardridge, W.M. (2004). Gene therapy of the brain: The trans-vascular approach. Neurology 62, 1275-1281. (Pubitemid 38526037)
26. Shen, F., Su, H., Fan, Y., Chen, Y., Zhu, Y., Liu, W., Young, W.L., and Yang, G.Y. (2006). Adeno-associated viral vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 37, 2601-2606. (Pubitemid 44454685)
27. Shi, N., and Pardridge, W.M. (2000). Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U.S.A. 97, 7567-7572. (Pubitemid 30431504)
28. Smith, M.W., and Gumbleton, M. (2006). Endocytosis at the blood-brain barrier: From basic understanding to drug delivery strategies. J. Drug Target. 14, 191-214.
29. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X.O., Logvinova, A., and Greenberg, D.A. (2003). VEGF-induced neuroprotection, neu-rogenesis and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851. (Pubitemid 38057729)
30. Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C., and Sharp, F.R. (1990). A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290-293. (Pubitemid 20096202)
31. Wang, R.Z., Zhang, X.F., Zhang, J., and Xiu, R. (2000). Gene transfer of vascular endothelial growth factor plasmid/lipo-some complexes in glioma. Clin. Hemorheol. Microcirc. 23, 303-306.
32. Xu, Z.H., Gu, W.W., Huang, J., Sui, H., Zhou, Z., Yang, Y., Yan, Z., and Li, Y. (2005). In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int. J. Pharm. 288, 361-368. (Pubitemid 40038589)
33. Yang, T., Cui, F.D., Choi, M.K., Cho, J.W., and Cho, J.W. (2007a). Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation. Int. J. Pharm. 338, 317-326. (Pubitemid 46777245)
34. Yang, T., Cui, F.D., Choi, M.K., Lin, H., Chung, S.J., Shim, C.K., and Kim, D.D. (2007b). Liposome formulation of paclitaxel with enhanced solubility and stability. Drug Deliv. 14, 301-308. (Pubitemid 47027038)
35. Zhang, Y., Schlachetzki, F., and Pardridge, W.M. (2003). Global non-viral gene transfer to the primate brain following intravenous administration. Mol. Ther. 7, 11-18. (Pubitemid 36305354)
36. Zhang, Z.G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N., and Chopp, M. (2000). VEGF enhances an-giogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838.
37. Zhao, H., Li, Y.N., Wang, R.Z., Bao, X.J., Zhao, Y.J., Li, G.L., and Wei, J.J. (2009a). Establishment of focal cerebral ischemia rat models in a novel efficient method. [Acta Laboratorium Ani-malis Scientia Sinica] 17, 432-436.
38. Zhao, H., Wang, R.Z., Wang, F., Zhang, Y.H., Chen, X.W., Li, X.R., Liu, Y., and Li, G.L. (2009b). Preparation of brain targeted immunoliposomes. Yao Xue Xue Bao [Acta Pharma-ceutica Sinica] 44, 1-6.
39. Zhu, W., Fan, Y.F., Hao, Q., Shen, F., Hashimoto, T., Yang, G.Y., Gasmi, M., Bartus, R.T., Young, W.L., and Chen, Y. (2009). Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental stroke. J. Cereb. Blood Flow Metab. 29, 1528-1537.